Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy 
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
OpenAI Explores Massive Funding Round at $750 Billion Valuation 
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role 
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns 
 2009-2020 - EconoTimes)
Dublin, Oct. 06, 2016 -- Research and Markets has announced the addition of the "Global Market Report On Rebamipide 2016" report to their offering.
The Global Market Report on Rebamipide provides comprehensive data on Rebamipide global and regional markets including Europe, Asia, North America, Latin America, etc. The report captures Rebamipide market trends and pays close attention to Rebamipide.
The report is broken into three main parts including manufacturing methods & technology development, market landscape & trend analysis, and distribution policy.
In the manufacturing methods & technology development section, the main manufacturing methods of Rebamipide are introduced.
Key Topics Covered:
Part 1: Introduction of Rebamipide
Chapter 1: Brief Introduction of Rebamipide
Chapter 2: Product Identification
Chapter 3: Physical Properties
Chapter 4: Quality Specifications
Part 2: Manufacture Methods and Technology Development of Rebamipide
Chapter 1: Introduction of Main Manufacture Methods
Chapter 2: Introduction of Patent Manufacture Methods
Chapter 3: New Progress on the Manufacture Technology
Part 3: Application of Rebamipide
Chapter 1: Application Review
Chapter 2: End Products(Downstream Products) of Rebamipide
Chapter 3: New Applications of Rebamipide
Part 4: Production Situation of Rebamipide
Chapter 1: Current Production Situation
Chapter 2: Manufacturers in China
Chapter 3: Manufacturers Outside of China
Chapter 4: Production Trend Analysis
Part 5: Market Situation of Rebamipide
Chapter 1: Market Supply Status and Trend Forecast
Chapter 2: Downstream Consumer Market Analysis
Chapter 3: Supply and Demand Analysis and Forecast
Chapter 4: Price Analysis
Chapter 5: Import & Export Situation
Part 6: Distribution Policy of Rebamipide
Chapter 1: Market Size in Major Use Segments
Chapter 2: Major End Users
Chapter 3: Potential Users
Part 7: References
For more information about this report visit http://www.researchandmarkets.com/research/j4lb8t/global_market
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Gastrointestinal Drugs
